Microbial Signature in Adipose Tissue of Crohn's Disease Patients

Autor: Marc Martí, Eloy Espin, Margarida Terrón-Puig, Aleidis Caro, Catalina Núñez-Roa, Joan Vendrell, Elsa Maymó-Masip, Maribel Queipo-Ortuño, M. Mar Rodríguez, Diandra Monfort-Ferré, Sonia Fernández-Veledo, Monica Millan, Carolina Serena, Lidia Sánchez-Alcoholado, Francisco J. Tinahones, Michelle Bautista, Margarita Menacho, Beatriz Espina

Publikováno v: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Journal of clinical medicine
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Journal of Clinical Medicine
Volume 9
Issue 8
Journal of Clinical Medicine, Vol 9, Iss 2448, p 2448 (2020)

Crohn&rsquo
s disease (CD) is characterized by compromised immune tolerance to the intestinal commensal microbiota, intestinal barrier inflammation, and hyperplasia of creeping fat (CF) and mesenteric adipose tissue (AT), which seems to be direc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dac6704097139d2f4965c1acae40e0ac
https://ddd.uab.cat/record/252818

The gut microbiota profile is associated with insulin action in humans

Autor: Alex Sánchez, Maribel Queipo-Ortuño, José María Moreno-Navarrete, José Manuel Fernández-Real, Rémy Burcelin, Francisco J. Tinahones, Eduardo García Fuentes, Matteo Serino

Publikováno v: Acta Diabetologica
Acta Diabetologica, Springer Verlag, 2013, 50 (5), pp.753-61. ⟨10.1007/s00592-012-0410-5⟩
Acta Diabetologica, 2013, 50 (5), pp.753-61. ⟨10.1007/s00592-012-0410-5⟩

International audience; The role of the gut microbiota in the induction of metabolic diseases has now been increasingly recognized worldwide. Indeed, a specific gut microbiota has been shown to characterize lean versus obese phenotypes both in humans

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf19fbfba101ef093e6e6bee913ce92b

P341 EFFECT OF APOCIII SSTI POLYMORPHISM IN POSTPRANDIAL RESPONSE TO A FAT OVERLOAD IN METABOLIC SYNDROME PATIENTS

Autor: Mercedes Clemente-Postigo, Francisco J. Tinahones, Fernando Cardona, Maribel Queipo-Ortuño

Publikováno v: Atherosclerosis Supplements. 11:89

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9f35c20e7e496308020be77e6c47d28f
https://doi.org/10.1016/s1567-5688(10)70408-6

Abstract: P923 OXIDATIVE STRESS AFTER FAT OVERLOAD IN PERSONS WITH BASELINE HYPERTRIGLYCERIDEMIA WITH OR WITHOUT THE METABOLIC SYNDROME

Autor: Maribel Queipo-Ortuño, Francisco J. Tinahones, Fernando Cardona, Mora Murri

Publikováno v: Atherosclerosis Supplements. 10:e1070

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::14850a4e413da27713bae9f105a6ed66
https://doi.org/10.1016/s1567-5688(09)71044-x

PPARγ mRNA expression is reduced in peripheral blood mononuclear cells after fat overload in patients with metabolic syndrome

Autor: Francisco J. Tinahones, Miguel A. Martín, Fernando Cardona, Rosa Bernal, Manuel Macias-Gonzalez, Maribel Queipo-Ortuño

Publikováno v: Scopus-Elsevier

PPARgamma is a transcriptional regulator of metabolism; its activity can be modulated by direct binding of dietary lipids. The most prevalent human PPARgamma gene variant, Ala12, is associated with postprandial hypertriglyceridemia in patients with m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29825a9b1bf515f1ba8c2b4efdcdb3fd
http://www.scopus.com/inward/record.url?eid=2-s2.0-42449116898&partnerID=MN8TOARS